Buy Aripiprazole

Aripiprazole

Aripiprazole: Generic Medication Overview

Aripiprazole is an atypical antipsychotic medication classified within the mental health therapeutic area. It is supplied as an oral pill in the strengths 5 mg, 10 mg, 15 mg, 20 mg, and 30 mg. In Hong Kong, aripiprazole is a prescription-only (Rx) medicine approved by the Department of Health’s Pharmacy and Poisons Board for several psychiatric indications. The active ingredient is aripiprazole itself; no additional brand names are required for this generic presentation.

How Aripiprazole Works in the Body

Aripiprazole acts as a partial agonist at dopamine D₂ and serotonin 5-HT₁A receptors while antagonising serotonin 5-HT₂A receptors. In plain language, the drug “dampens” excessive dopamine activity that contributes to psychotic symptoms, yet still allows enough dopamine signaling to avoid the severe side-effects often seen with full dopamine blockers. Its mixed activity helps stabilise mood and reduces the risk of relapse in conditions such as schizophrenia and bipolar disorder. The medication is well absorbed after oral ingestion, reaches peak plasma concentrations within 3-4 hours, and has a long elimination half-life of about 75 hours, which supports once-daily dosing.

Conditions Treated by Aripiprazole

• Schizophrenia (adults) - to lessen hallucinations, delusions, and disorganized thinking.
• Bipolar I disorder - for acute manic, mixed, or maintenance phases.
• Adjunctive treatment of major depressive disorder - used together with an antidepressant when response is insufficient.
• Irritability associated with autistic disorder (in some jurisdictions) - helps reduce aggression and mood swings.

These uses are approved by major regulatory agencies, including the U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA), and are reflected in Hong Kong’s product registration.

Evidence-Based Off-Label Uses

• Tourette’s disorder - Small controlled studies suggest a reduction in tic severity, but evidence remains limited.
• Obsessive-compulsive disorder (OCD) - Case series report benefit when added to standard therapy; robust trials are lacking.

Disclaimer: Off-label use is not approved by the Department of Health in Hong Kong. It requires careful medical supervision and an individualized risk-benefit assessment.

Evaluating Aripiprazole for Your Health Profile

Absolute contraindications

• Known hypersensitivity to aripiprazole or any of its excipients.

Relative contraindications / cautions

• History of neuroleptic malignant syndrome or severe tardive dyskinesia.
• Uncontrolled cardiovascular disease or existing QTc prolongation (electro-cardiogram monitoring advised).
• Pregnancy - classified as Category C; use only if potential benefit justifies the risk.
• Breast-feeding - aripiprazole is excreted in milk; weighing maternal benefit against infant exposure is essential.

Special populations

• Pediatric: Approved for children ≥ 6 years with schizophrenia and ≥ 13 years with bipolar disorder; dosing is weight-based.
• Elderly: Start at the lowest possible dose and titrate slowly due to heightened sensitivity to side effects such as orthostatic hypotension.
• Hepatic impairment: Moderate to severe liver disease warrants a dose reduction because aripiprazole is primarily metabolised by the liver.

Safety Profile and Interactions

Common Side Effects

• Akathisia (inner restlessness) - reported in up to 20 % of patients; may improve with dose adjustment.
• Nausea, vomiting, or constipation - usually mild and transient.
• Headache and insomnia - frequently noted during the first weeks of therapy.
• Weight gain - less pronounced than with some older antipsychotics but still possible.

Serious Adverse Events

• Tardive dyskinesia - potentially irreversible involuntary movements; monitor regularly.
• Neuroleptic malignant syndrome - rare but life-threatening; characterised by fever, muscle rigidity, autonomic instability.
• Suicidal thoughts - increased risk in children, adolescents, and young adults with depressive disorders.
• Metabolic changes - hyperglycaemia, dyslipidaemia, and increased blood pressure may develop with prolonged use.

Drug Interactions

• CYP3A4 inhibitors (e.g., ketoconazole, clarithromycin) - can raise aripiprazole levels; dose reduction may be needed.
• CYP2D6 inhibitors (e.g., fluoxetine, paroxetine) - raise aripiprazole concentrations; monitor for enhanced side effects.
• CYP3A4 inducers (e.g., carbamazepine, phenytoin) - may lower aripiprazole levels, possibly reducing efficacy.
• Other antipsychotics or dopaminergic agents - increase risk of additive side effects such as extrapyramidal symptoms.

Food and Lifestyle Interactions

• Food does not significantly affect aripiprazole absorption; the pill may be taken with or without meals.
• Alcohol can intensify sedation and dizziness; limit intake, especially when initiating therapy.
• Caution when operating machinery or driving until the individual’s response to the medication is known.

How to Take Aripiprazole

• Standard dosing for schizophrenia - start with 5 mg once daily; increase in 5 mg increments to a typical maintenance range of 10-30 mg daily based on response and tolerability.
• Bipolar I disorder - initial dose of 15 mg daily; may be adjusted to 15-30 mg as needed.
• Adjunctive depression - clinicians often begin with 2-5 mg (if a lower strength is available); the target range is 5-15 mg.

All doses listed correspond to the available tablet strengths (5 mg-30 mg).

• Special populations - for patients with moderate hepatic impairment, a 50 % dose reduction is common practice. No routine adjustment is required for renal dysfunction.
• Administration - swallow the tablet whole with water; do not crush or chew unless a specific formulation allows it.
• Missed dose - take the missed dose as soon as remembered unless the next scheduled dose is within 12 hours; in that case, skip the missed dose and continue the regular schedule. Do not double the dose.
• Overdose - symptoms may include extreme drowsiness, rapid heart rate, and low blood pressure. Seek emergency medical care; supportive measures and cardiac monitoring are standard.
• Discontinuation - abrupt cessation can lead to relapse or withdrawal-like symptoms. Gradual tapering, especially after long-term use, is advisable under medical guidance.

Monitoring and Follow-Up

• Baseline and periodic assessments of weight, fasting glucose, lipid profile, and blood pressure.
• Electro-cardiogram (ECG) if the patient has cardiac risk factors or is on medications that prolong the QT interval.
• Mental status examinations to gauge efficacy and early signs of relapse.
• Suicidality screening for younger patients and those treated for depression.

Regular follow-up appointments enable dose adjustments and early detection of adverse effects.

Storage and Handling

• Store tablets at room temperature (20 °C-25 °C), away from excess heat, moisture, and direct sunlight.
• Keep the container tightly closed and out of reach of children.
• Do not use the medication past the expiry date printed on the package; discard any expired tablets according to local pharmacy guidelines.

Medication-Specific Glossary

Partial Agonist

A drug that binds to a receptor and activates it, but produces a weaker response than a full agonist, allowing a modulating effect.

Akathisia

A movement disorder characterised by an inner feeling of restlessness and a compelling need to move, often experienced as an uncomfortable urge to pace.

Tardive Dyskinesia

Potentially irreversible, involuntary, repetitive movements (often of the face or tongue) that can occur after long-term antipsychotic use.

Neuroleptic Malignant Syndrome

A rare, life-threatening reaction to antipsychotics marked by high fever, severe muscle rigidity, autonomic instability, and altered mental status.

QTc Prolongation

An extension of the corrected QT interval on an ECG, which can increase the risk of a potentially fatal arrhythmia called torsades de pointes.

Medical Disclaimer

This article provides educational information about aripiprazole and is not a substitute for professional medical advice. Treatment decisions, including use for unapproved indications, must be made under the guidance of a qualified healthcare provider. The content is intended for informational purposes and does not constitute medical recommendations. Always consult a physician before starting, stopping, or changing any medication regimen.